Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
NCT06498310 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-07-12
Summary
Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.
Conditions
- Invasive Fungal Infections
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-08
- Primary Completion
- 2025-11-30
- Completion
- 2025-11-08
Countries
- France
Study Locations
More Related Trials
-
Evaluation of a Clinical Decision Support System for Fungal Infections
NCT05656157 ·Status: COMPLETED
-
Prophylaxis With Caspofungin in High-Risk Liver Transplantation
NCT00333645 ·Status: UNKNOWN ·Phase: PHASE2
-
Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
NCT06346951 ·Status: NOT_YET_RECRUITING
-
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
NCT00003883 ·Status: COMPLETED ·Phase: PHASE3
-
Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants
NCT00143312 ·Status: COMPLETED ·Phase: PHASE4
-
A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation
NCT01519648 ·Status: COMPLETED
-
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
NCT01503515 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants
NCT00001107 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosis of Lymphohistiocytic Hemophagocytosis in Intensive Care
NCT07343037 ·Status: RECRUITING
-
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
NCT00075803 ·Status: COMPLETED ·Phase: PHASE3
-
Perception and Prevalence of Fungal Infections in Berlin - Brandenburg
NCT01393002 ·Status: COMPLETED
-
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
NCT04368559 ·Status: COMPLETED ·Phase: PHASE3
-
Posaconazole vs Itraconazole in Preventing IFD Post-HSCT
NCT03631602 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sautour PHRC IR 2008
NCT02859831 ·Status: COMPLETED
-
Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients
NCT01260974 ·Status: UNKNOWN ·Phase: PHASE2
-
Variability of Fluconazole Concentration in Critically Ill Patients
NCT02491151 ·Status: COMPLETED
-
Factors Associated With Survival in Patients Having Pneumocystis Jirovecii
NCT06173453 ·Status: UNKNOWN
-
Surveillance of Fungal Infections During Construction Activity
NCT00473252 ·Status: COMPLETED
-
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 ·Status: COMPLETED ·Phase: PHASE3
-
Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)
NCT01888458 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
NCT06344117 ·Status: RECRUITING
-
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
NCT00841971 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy
NCT01439646 ·Status: COMPLETED
-
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI)
NCT06541067 ·Status: RECRUITING ·Phase: PHASE2
-
King's Invasive Aspergillosis Study II
NCT02875743 ·Status: COMPLETED ·Phase: PHASE4